文献速递消化系统肿瘤支持与姑息治疗

儿童癌症幸存者腹盆腔放疗后后续结直肠癌的累积绝对风险:PanCareSurFup研究

Cumulative Absolute Risk of Subsequent Colorectal Cancer After Abdominopelvic Radiotherapy Among Childhood Cancer Survivors: A PanCareSurFup Study.
PubMed 文献 · J Clin Oncol · 2023-11-16

该研究基于PanCareSurFup病例对照研究(143例结直肠癌病例和143例对照,嵌套于69,460例幸存者队列),量化腹盆腔放疗后后续结直肠癌的累积绝对风险。结果显示,接受腹盆腔放疗的幸存者发生后续结直肠癌的风险是未接受者的三倍(OR 3.1,95%CI 1.4-6.6)。男性幸存者40岁、50岁、60岁的累积绝对风险分别为0.27%、1.08%、3.7%,女性分别为0.29%、1.03%、3.0%,均高于一般人群预期。

要点

  • 接受腹盆腔放疗的儿童癌症幸存者后续结直肠癌风险是未接受者的3.1倍(95%CI 1.4-6.6)。
  • 男性幸存者60岁时累积绝对风险为3.7%(95%CI 2.36-7.80),一般人群预期为0.95%。
  • 女性幸存者60岁时累积绝对风险为3.0%(95%CI 1.91-6.37),一般人群预期为0.82%。

核心结论

  • 接受腹盆腔放疗的儿童癌症幸存者在40岁时结直肠癌风险已与一般人群50岁(许多国家开始筛查的年龄)相似。
  • 该信息应被用于制定幸存者随访指南,以对幸存者的结直肠癌风险进行风险分层。

研究设计与样本

  • PanCareSurFup研究是一项泛欧洲病例对照研究,嵌套于69,460例儿童癌症幸存者的大型队列中。
  • 病例对照研究纳入143例结直肠癌病例和143例对照,计算比值比(OR)。
  • 结合该队列结直肠癌标准化发病比、欧洲一般人群结直肠癌发病率和幸存者死亡率,按腹盆腔放疗类别估算达到年龄的累积绝对风险(CAR)。

主要发现

  • 接受腹盆腔放疗的幸存者发生后续结直肠癌的风险是未接受者的三倍(OR 3.1,95%CI 1.4-6.6)。
  • 男性幸存者接受腹盆腔放疗后,40岁累积绝对风险为0.27%(95%CI 0.17-0.59),50岁为1.08%(95%CI 0.69-2.34;一般人群预期0.27%),60岁为3.7%(95%CI 2.36-7.80;一般人群预期0.95%)。
  • 女性幸存者接受腹盆腔放疗后,40岁累积绝对风险为0.29%(95%CI 0.18-0.62),50岁为1.03%(95%CI 0.65-2.22;一般人群预期0.27%),60岁为3.0%(95%CI 1.91-6.37;一般人群预期0.82%)。

临床怎么用

  • 作者认为,该信息应被用于制定幸存者随访指南,以对幸存者的结直肠癌风险进行风险分层。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Childhood cancer survivors are at the risk of developing subsequent colorectal cancers (CRCs), but the absolute risks by treatment modality are uncertain. We quantified the absolute risks by radiotherapy treatment characteristics using clinically accessible data from a Pan-European wide case-control study nested within a large cohort of childhood cancer survivors: the PanCareSurFup Study. METHODS: Odds ratios (ORs) from a case-control study comprising 143 CRC cases and 143 controls nested within a cohort of 69,460 survivors were calculated. These, together with standardized incidence ratios for CRC for this cohort and European general population CRC incidence rates and survivors' mortality rates, were used to estimate cumulative absolute risks (CARs) by attained age for different categories of radiation to the abdominopelvic area. RESULTS: Overall, survivors treated with abdominopelvic radiotherapy treatment (ART) were three times more likely to develop a subsequent CRC than those who did not receive ART (OR, 3.1 [95% CI, 1.4 to 6.6]). For male survivors treated with ART, the CAR was 0.27% (95% CI, 0.17 to 0.59) by age 40 years, 1.08% (95% CI, 0.69 to 2.34) by age 50 years (0.27% expected in the general population), and 3.7% (95% CI, 2.36 to 7.80) by age 60 years (0.95% expected). For female survivors treated with ART, the CAR was 0.29% (95% CI, 0.18 to 0.62) by age 40 years, 1.03% (95% CI, 0.65 to 2.22) by age 50 years (0.27% expected), and 3.0% (95% CI, 1.91 to 6.37) by age 60 years (0.82% expected). CONCLUSION: We demonstrated that by age 40 years survivors of childhood cancer treated with ART already have a similar risk of CRC as those age 50 years in the general population for whom population-based CRC screening begins in many countries. This information should be used in the development of survivorship guidelines for the risk stratification of survivors concerning CRC risk.

来源:J Clin Oncol,查看原文。版权归原作者所有。

引用

  1. Heymer EJ, Jóźwiak K, Kremer LC, et al. Cumulative Absolute Risk of Subsequent Colorectal Cancer After Abdominopelvic Radiotherapy Among Childhood Cancer Survivors: A PanCareSurFup Study. J Clin Oncol. 2023. PMID: 37972325. doi:10.1200/JCO.23.00452

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。